Pourhassan, H.; Nguyen, T.; Yang, D.; Otoukesh, S.; Arslan, S.; Blackmon, A.; Agrawal, V.; Amanam, I.; Ball, B.; Koller, P.;
et al. Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers 2024, 16, 3912.
https://doi.org/10.3390/cancers16233912
AMA Style
Pourhassan H, Nguyen T, Yang D, Otoukesh S, Arslan S, Blackmon A, Agrawal V, Amanam I, Ball B, Koller P,
et al. Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers. 2024; 16(23):3912.
https://doi.org/10.3390/cancers16233912
Chicago/Turabian Style
Pourhassan, Hoda, Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan, Amanda Blackmon, Vaibhav Agrawal, Idoroenyi Amanam, Brian Ball, Paul Koller,
and et al. 2024. "Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)" Cancers 16, no. 23: 3912.
https://doi.org/10.3390/cancers16233912
APA Style
Pourhassan, H., Nguyen, T., Yang, D., Otoukesh, S., Arslan, S., Blackmon, A., Agrawal, V., Amanam, I., Ball, B., Koller, P., Salhotra, A., Aribi, A., Becker, P., Curtin, P., Artz, A., Aldoss, I., Ali, H., Stewart, F., Smith, E.,
... Al Malki, M. M.
(2024). Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers, 16(23), 3912.
https://doi.org/10.3390/cancers16233912